Results 261 to 270 of about 10,895,625 (310)

Patterns of central nervous system and leptomeningeal involvement in advanced breast cancer with invasive lobular histology: a large multicenter study with a focus on estrogen receptor-positive/HER2-negative disease. [PDF]

ESMO Open
Miglietta F, Vernieri C, Giarratano T, Griguolo G, Bottosso M, Vingiani A, Piacentini F, Cacciatore M, Botticelli A, Fotia G, Napolitano P, Landa G, Vernaci GM, Di Liso E, Casadei L, Palleschi D, Pruneri G, Dei Tos AP, Guarneri V, Dieci MV.   +19 more
europepmc   +1 more source

Germline pharmacogenetic variants associated with trastuzumab deruxtecan-induced interstitial lung disease in advanced breast cancer: PROCURE project. [PDF]

ESMO Open
Arenas A, Saura C, Alva-Bianchi M, de Nicolás-Hernández J, Gion M, Cejalvo JM, Llabrés E, Cortés J, Falcón A, Pernas S, López de Sa A, Vidal M, Hinojo C, Curiel T, Cruz J, Martínez V, Cantos B, Echarri MJ, Gallegos I, Bueno C, Vargas AM, Escrivá-de-Romaní S, Fullana B, Cobos MA, Joval-Ramentol L, Ortiz-Heras P, Pascual T, Valdivia C, Villacampa G, Ciruelos E, Rodriguez-Antona C, Sánchez-Bayona R.   +31 more
europepmc   +1 more source

Identification and treatment of GOLD stages I and II chronic obstructive pulmonary disease. [PDF]

J Thorac Dis
Guan WJ, Chalmers JD, Sun YC, Agusti A, Ran PX, Halpin D, Li SY, Criner G, Zhou YM, Usmani O, Chen RC, Anzueto A, Wen FQ, Vogelmeire C, Salvi S, Zheng JP, Zhong NS.   +16 more
europepmc   +1 more source

Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial.

JAMA Dermatol
Mangold AR, Haemel A, Shahriari N, Chong B, Fernandez AP, Fiorentino D, Pearson D, Sluzevich J, Onajin O, Rambhatla PV, Rashighi M, Hurabielle C, Fivenson D, Boh E, Paravar T, Crew A, Flowers RH, Taylor D, Subhadarshani S, Culton D, Schadt C, Callen J, Lam C, Graham L, Hashemi K, Castillo R, Maderal A, Elman S, Shaw KS, Cascino MD, LaChance A, Min MS, Femia A, Vleugels RA, Werth VP.   +34 more
europepmc   +1 more source

Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure: The FINEARTS-HF Randomized Clinical Trial.

JAMA Cardiol
Ostrominski JW, Mc Causland FR, Claggett BL, Desai AS, Jhund PS, Henderson A, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Amarante F, Brinker M, Schloemer P, Rohwedder K, McMurray JJV, Solomon SD, Vaduganathan M.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MEDICAL FEES

BMJ, 1908
W. Gosse
openaire   +2 more sources

Medical Fees

Public Health Economics, 1958
openaire   +2 more sources

MEDICAL FEES

Medical Journal of Australia, 1974
openaire   +2 more sources

FDA Regulation and Approval of Medical Devices: 1976-2020.

Journal of the American Medical Association (JAMA), 2021
Importance US law generally requires testing of high-risk medical devices prior to approval, as well as premarket evaluation of moderate-risk medical devices, with the goal of ensuring that the benefits of these products exceed their risks.
Jonathan J. Darrow, J. Avorn, A. Kesselheim   +2 more
semanticscholar   +1 more source

Intended and unintended impacts of price changes for drugs and medical services: Evidence from China.

Social Science & Medicine (1967), 2018
In 2012, the Chinese government launched a nationwide reform of county-level public hospitals with the goal of controlling the rapid growth of healthcare expenditure. The key components of the reform were the zero markup drug policy (ZMDP), which removed
Hongqiao Fu, Ling Li, W. Yip
semanticscholar   +1 more source